Envoy Medical Stock (NASDAQ:ANZU)

Revenue Ownership Financials Chart

Previous Close

$5.64

52W Range

$5.21 - $11.72

50D Avg

$10.12

200D Avg

$10.09

Market Cap

$102.47M

Avg Vol (3M)

$35.22K

Beta

0.03

Div Yield

-

ANZU Company Profile

Anzu Special Acquisition Corp I does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of industrial applications. The company was incorporated in 2020 and is based in Tampa, Florida.

Industry

Shell Companies

Sector

Financial Services

Exchange

NASDAQ

ADR

-

Country

US

Employees

-

IPO Date

Apr 29, 2021

Website

ANZU Performance

ANZU Financial Summary

	Dec 23	Dec 22	Dec 21
Revenue	$316.00K	$237.00K	$310.00K
Operating Income	$-18.37M	$-8.71M	$-6.87M
Net Income	$-29.91M	$-15.92M	$-8.68M
EBITDA	$-18.24M	$-8.63M	$-6.80M
Basic EPS	$-2.38	$-1.57	$-0.85
Diluted EPS	$-2.38	$-1.57	$-0.85

Fiscal year ends in Dec 23 | Currency in USD

Peer Comparison

Ticker	Company
ARIZ	Arisz Acquisition Corp.